Chinese medicinal composition for treating malignant tumor and preparation method thereof

Abstract

The invention discloses a Chinese medicinal composition for treating malignant tumor, belonging to the field of Chinese medicines. The Chinese medicinal composition is a medicament preparation formed from herba oldenlandiae, astragalus root, tuckahoe, prepared pinellia tuber, herba scutellariae barbatae, teloon, scorpion, scolopendra and the like by adopting advanced processes including extraction with water, extraction with ethanol, enzymolysis of trypsinase and the like according to a certain compatible requirement, and the medicament preparation is preferably prepared into capsules and tablets. The Chinese medicinal composition has a certain function for relieving symptoms for lung cancer, liver cancer, gastric cancer, intestinal cancer, breast cancer, encephaloma, lymph cancer and other malignant tumors, reducing tumor bodies, inhibiting the growth of the tumors and the like; and according to the Chinese medicinal composition, the human immune capability can be improved, the lives of patients suffered from tumors can be prolonged and the adverse reactions of leukocytopenia, dizzy, weakness and fatigue, skinniness, poor appetite, nausea and vomiting and the like due to radiotherapy chemotherapy for cancers can be effectively relieved.

Description

technical field [0001] The invention relates to a pharmaceutical composition and a preparation method of the composition, in particular to a traditional Chinese medicine composition for treating malignant tumors and a preparation method thereof, belonging to the field of traditional Chinese medicine. Background technique [0002] At present, cancer has become one of the diseases that seriously endanger human health and is difficult to cure. It is the second largest killer of human beings after cardiovascular disease, and has become a serious public health problem. With the change of human living environment and living habits and the acceleration of the pace of life, the incidence of tumors is gradually increasing. According to WTO statistics, the average number of deaths from malignant tumors in the world is 6.9 million per year, and there are about 10 million new cases, which are still increasing year by year; Developing countries in Asia, Africa and Latin America. In my ...

AI Technical Summary

Problems solved by technology

[0003] However, despite the continuous advancement of science and technology today, the treatment of tumors is still not ideal

Clinically, the treatment of malignant tumors is still dominated by surgery, radiotherapy and chemotherapy, but surgery or radiotherapy is only suitable for some patients with early stage non-diffusion, which belongs to local treatment; while chemotherapy for tumors is still mainly based on chemically synthesized drugs, such as cyclophosphamide, Carboplatin, cisplatin, Gemzetin, pemetrexed, etc., although most of them have good antitumor effects, have extensive and serious side effects, mainly manifested as bone marrow suppression, gastrointestinal symptoms, mucous membrane, hair damage, heart, liver, lung , nephrotoxicity, and neurotoxicity lead to overall immune function damage, which often leads to the deterioration of the patient's body condition and the decline in the quality of life. Long-term application effect is not good

The reason is that Western medicine only focuses on indicators such as chemotherapy index and tumor inhibition rate in the treatment of tumors, and seldom considers the overall situation of tumor patients, especially the quality of life of patients.

Images